Researchers have found that the use of predictive biomarkers along with two targeted treatments significantly delays the need for conventional chemotherapy in patients with early-stage, but high-risk, chronic lymphoid leukemia.
Read More
Carolina Chemistries, R&D Systems, RNA Medical, Sebia, Streck, Sysmex, The Binding Site, Thermo Fisher Scientific, Vital Diagnostics
Read MoreFindings in an upcoming publication in the Journal of Molecular Diagnostics show CombiMatrix’s HemeScan test is superior to conventional testing for the clinical evaluation and prognosis of CLL patients.
Read More
Xpert BCR-ABL Monitor Assay for the GeneXpert System CML genetic marker assay The Xpert BCR-ABL monitor from Cepheid, Sunnyvale, Calif, can be used by hematologist-oncologists and laboratorians as an aid in the monitoring of BCR-ABL, an
Read MoreThe FDA has approved the fully automated HTLV-I/HTLV-II blood-screening test from Abbott, Abbott Park, Ill, for use on the companys Prism instrument.
Read More